Pegfilgrastim Recruiting Phase 2 Trials for Neutropenias Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01918241Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia